Policy Brief

Our Policy Brief presents research in a clear, concise, and engaging format, designed to support high-level executives and policy decision-makers in using evidence-based information to inform effective policy development and implementation.
Highlight Policy Brief

No information found

Policy Brief 56 issues
All (56)
Antimicrobial Resistance Policy in Thailand
Antimicrobial Resistance Policy in Thailand
By : Chris Painter, Aparna Ananthakrishnan
Addressing Antimicrobial Resistance in Thailand: A Policy Overview
Issue No. 19
Addressing Antimicrobial Resistance in Thailand: A Policy Overview
By : Chris Painter, Aparna Ananthakrishnan
Evaluating the Value of a Real-World HTA Agency
Evaluating the Value of a Real-World HTA Agency
Rationing scarce critical-care resources during the COVID-19 pandemic in Thailand
Issue No. 73
Rationing scarce critical-care resources during the COVID-19 pandemic in Thailand
By : Kanchanok Sirison
Budgeting and paying for services under Thailand’s Universal Coverage Scheme
Issue No. 17
Budgeting and paying for services under Thailand’s Universal Coverage Scheme
By : Viroj Tangcharoensathien, Walaiporn Patcharanarumol, Taweesri Greetong, Waraporn Suwanwela, Nantawan Kesthom, Shaheda Viriyathorn, Nattadhanai Rajatanavin, Woranan Witthayapipopsakul
Good Governance for Universal Health Coverage
Issue No. 18
Good Governance for Universal Health Coverage
By : นพ.สมศักดิ์ ชุณหรัศมิ์, Juliet Amanda Rose Eames
Cutting Future Healthcare Cost through Population-wide Sodium Reduction Policy
Issue No. 77
Cutting Future Healthcare Cost through Population-wide Sodium Reduction Policy
By : Pritaporn Kingkaew, PhD., Juthamas Prawjaeng
Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
Issue No. 16
Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
By : Wanrudee Isaranuwatchai, PhD, Pritaporn Kingkaew, PhD., Pempa Pempa, Deepika Adhikari, Alia Luz, Nantasit Luangasanatip, Frederic Debellut
Building Global Health Capacity for Countries in WHO South-East Asia Region
Issue No. 58
Building Global Health Capacity for Countries in WHO South-East Asia Region
By : Akanittha Poonchai, Songyot Pilasan
Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
Issue No. 14
Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
By : Amila Megraini, Ery Setiawan, Siti Rizny F. Saldi, Ryan R. Nugraha, Septiara Putri, Levina Chandra Khoe, Vetty Yulianty
Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?
Issue No. 15
Should high-cost bevacizumab be used for metastatic-colorectal cancer (mCRC) treatment in JKN in Indonesia?
By : Dwi Endarti, Erna Kristin, Rizaldy Pinzon, Woro Rukmi Pratiwi, Dwi Aris Agung Nugrahaningsih, Didik Setiawan, Christiana Trijayanti, Alfi Yasmina, Tri Murti Andayani
Designing the Health Benefit Package: The essential component of a successful universal health coverage program
Issue No. 10
Designing the Health Benefit Package: The essential component of a successful universal health coverage program
By : Yot Teerawattananon, PhD., Saudamini Vishwanath Dabak, Juliet Amanda Rose Eames
12 / Pages